These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17354591)

  • 41. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies.
    Tincani A; Allegri F; Balestrieri G; Reber G; Sanmarco M; Meroni P; Boffa MC
    Thromb Res; 2004; 114(5-6):553-8. PubMed ID: 15507291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid syndrome review.
    Eby C
    Clin Lab Med; 2009 Jun; 29(2):305-19. PubMed ID: 19665680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-phosphatidylinositol antibodies and their determination using our ELISA method].
    Fialová L; Mikulíková L; Fisar Z; Beitlová D; Malbohan I
    Sb Lek; 1996; 97(4):463-7. PubMed ID: 9424711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
    Kriseman YL; Nash JW; Hsu S
    J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the variation in antiphospholipid antibody (APA) assays: comparison of results from 10 centers.
    Kutteh WH; Franklin RD
    Am J Obstet Gynecol; 2004 Aug; 191(2):440-8. PubMed ID: 15343219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiphospholipid antibodies and the antiphospholipid antibody syndrome.
    Nahass GT
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):149-68; quiz 169-72. PubMed ID: 9039162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-date on the antiphospholipid syndrome.
    Luzzana C; Gerosa M; Riboldi P; Meroni PL
    J Nephrol; 2002; 15(4):342-8. PubMed ID: 12243362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification.
    Ruffatti A; Olivieri S; Tonello M; Bortolati M; Bison E; Salvan E; Facchinetti M; Pengo V
    J Thromb Haemost; 2008 Oct; 6(10):1693-6. PubMed ID: 18680541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antiphospholipid syndrome: serological markers, diagnostic criteria, clinical manifestations, classification, prognosis].
    Reshetniak TM; Alekberova ZS
    Ter Arkh; 1998; 70(12):74-8. PubMed ID: 10067260
    [No Abstract]   [Full Text] [Related]  

  • 52. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
    Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL
    Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-phospholipid syndrome: clinical spectrum and therapeutical/prophylactic strategies in the pediatric population.
    Rigante D; Gaspari S; Bersani G; Stabile A
    Eur Rev Med Pharmacol Sci; 2008; 12(1):47-53. PubMed ID: 18401972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis C virus, antiphospholipid antibodies, and thrombosis.
    Violi F; Ferro D; Basili S
    Hepatology; 1997 Mar; 25(3):782. PubMed ID: 9049240
    [No Abstract]   [Full Text] [Related]  

  • 57. The clinical spectrum of antiphospholipid syndrome.
    Baker WF; Bick RL
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):33-52, v-vi. PubMed ID: 18207064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The antiphospholipid syndrome--yesterday, today, tomorrow].
    Stefanović D; Mitrović D; Pejnović N; Popović M
    Vojnosanit Pregl; 1998; 55(2 Suppl):5-12. PubMed ID: 9623352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Blood Rev; 2008 Mar; 22(2):93-105. PubMed ID: 17964017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.